Angina: A missed medical opportunity
Best initial management of stable angina starts with correct assessment; lifestyle management, anti-ischaemic drugs and prevention of adverse CV events are key, the role of revascularisation is now confined to specific subgroups
You will learn:
• That angina patients are often mis-assessed in terms of symptom management and risk classification
• The factors that contribute to the development of angina
• The decreasing role for revascularisation in favour of optimal medical therapy for the treatment of angina
• Practical recommendations for selecting anti-ischaemic drugs and for secondary prevention with antithrombotic therapy.
WEBINAR HELD ON 18 MARCH 2021
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.
To access this module, please register or login: